(MENAFN- Comserve) Shibuya-ku, Tokyo, Japan, Japan, Nov 11, 2021, 00:36 /Comserve / -- According to IQ4I analysis, the cardiac electrophysiology mapping, navigation and recording devices global market ...

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced FDA clearance of its EnSite Precision™ cardiac mapping system and Advisor™ FL ...

- EnSite™ X EP System with EnSite Omnipolar Technology (OT) provides a 360-degree view of the heart, regardless of catheter orientation, for cardiac mapping without compromise ABBOTT PARK, Ill., Jan.

AUSTIN, Texas, Dec. 4, 2024 /CNW/ -- Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center recently became the first in the nation to use an all-in-one ...

COPENHAGEN, Denmark, June 16, 2025 /PRNewswire/ -- CathVision, a leader in advanced cardiac electrophysiology (EP) technology, has developed a new algorithmic tool (PFAnalyzer) to help physicians ...

Stereotaxis CEO David Fischel says the MAGiC catheter was designed "to overcome the natural limitations of manual pull-wire ...

Abbott Laboratories received FDA 510(k) clearance for the Ensite X EP system with Ensite omnipolar technology, the company’s cardiac mapping platform. The system, which is used to identify and treat ...

Medtronic kicked off the week with news that it plans to strengthen its cardiac ablation buiness with the acquisition of Affera for an undisclosed sum. The deal also provides Medtronic with an entry ...

Please provide your email address to receive an email when new articles are posted on . Abbott announced its cardiac mapping platform for electrophysiology procedures received clearance from the FDA.

DUBLIN--(BUSINESS WIRE)--The "Cardiac Electrophysiology Mapping, Navigation and Recording Devices Global Market - Forecast to 2024" report has been added to ResearchAndMarkets.com's offering. The ...